Corvidia
Creating precision therapies by using the science of genomics in new ways.
Launch date
Employees
Market cap
-
Enterprise valuation
$2.1b (Public information from Jun 2020)
Waltham Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Seed | ||
$26.0m | Series A | ||
$60.0m | Series B | ||
$2.1b Valuation: $2.1b | Acquisition | ||
| Total Funding | $86.0m | ||
Related Content
Recent News about Corvidia
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.